Practice Operations · For practice managers
Open System vs Closed System PRP Centrifuges Cost Analysis
Published November 17, 2026
- Primary Cost Driver
- Recurring Consumables
- Regulatory Distinction
- FDA 510(k) Clearance
- Workflow Variance
- Operator Dependency
Over a multi-year lifecycle, per-procedure disposable kits and staff labor outweigh the upfront capital cost of the centrifuge hardware.
Dedicated closed PRP systems hold specific clearance for autologous biologic preparation, whereas standard lab tubes are cleared only for diagnostic testing.
Open manual pipetting introduces technician-to-technician variability in platelet yield and red blood cell contamination compared to mechanical closed separation.
An open system vs closed system PRP centrifuges cost analysis comes down to a tradeoff between low per-treatment consumable expenses and higher labor, contamination risk, and regulatory exposure. While open systems utilize inexpensive standard laboratory tubes, closed systems use FDA-cleared, pre-packaged kits that keep blood isolated from ambient air, reducing technician hands-on time, ensuring repeatable platelet concentrations, and protecting the practice from compliance liabilities.
For medical practice managers overseeing procurement in orthopedics, aesthetics, or regenerative medicine, evaluating platelet-rich plasma (PRP) equipment requires looking beyond the upfront price of the centrifuge hardware. The true total cost of ownership (TCO) is driven by recurring consumable costs, staff time per draw, waste from failed spins, and risk management.
Defining the Systems: Open vs. Closed PRP Preparation
Before modeling the financials, practice administrators and clinical leads must align on how these two categories function mechanically and regulatory-wise.
What is an Open PRP System?
An open system typically relies on a general-purpose laboratory centrifuge paired with standard blood collection tubes. During processing, the technician draws the whole blood, spins it, removes the stoppers or caps, and manually pipettes the platelet-rich plasma layer into a separate syringe—exposing the blood product to the ambient air of the procedure room. Unless performed under a certified laminar flow hood with strict environmental controls, open processing introduces potential airborne contamination.
What is a Closed PRP System?
A closed system uses a specialized centrifuge and proprietary, single-use disposable kits (tubes, hourglass chambers, or dual-syringe mechanisms) that maintain a sterile barrier throughout the entire separation process. Blood enters via a closed needle-less port, separates mechanically or via gel/buffle-coat valves during centrifugation, and is extracted into the treatment syringe without ever contacting room air. These systems are specifically evaluated under FDA 510(k) clearances for the safe and rapid preparation of autologous platelet-rich plasma.
Open System vs Closed System PRP Centrifuges Cost Analysis: Core Financial Drivers
When building a pro forma for a new or expanding biologics service line, practice managers should categorize expenses into four operational buckets.
1. Capital Equipment vs. Consumable Pricing Models
In medical device procurement, centrifuge hardware is rarely the primary cost driver over a multi-year horizon.
- Open System Hardware and Consumables: Standard lab centrifuges carry a low upfront capital cost. The daily disposables—standard vacutainer tubes, anticoagulants, spinal needles, transfer pipettes, and syringes—represent a very low direct material cost per patient.
- Closed System Hardware and Consumables: Dedicated PRP centrifuges may be purchased outright, leased, or placed in a clinic under a reagent-rental agreement tied to minimum monthly kit orders. The proprietary single-use kits represent a higher fixed cost per procedure, as they bundle the collection mechanism, anticoagulant, separation chamber, and extraction ports into one sterile package.
2. Staff Labor, Training, and Workflow Efficiency
A narrow focus on consumable unit cost often obscures the hidden labor expense of open systems.
- Technician Time: Open systems require multi-step manual pipetting, visual estimation of the buffy coat, and manual transfers between tubes for double-spin protocols. This keeps a medical assistant or registered nurse occupied at the bench for a longer window.
- Training and Turnover: Because open pipetting is highly operator-dependent, onboarding new clinical staff takes longer. If a technician misjudges the meniscus during extraction, the sample can be compromised, forcing a redraw or delivering a sub-therapeutic dose.
- Closed System Automation: Closed kits standardize the extraction phase. Many utilize mechanical valves, floating shelves, or push-through syringe designs that isolate the desired layer automatically. This allows the medical assistant to start the spin, prep the patient room, and perform the final draw-off in minutes.
3. Regulatory Compliance and Liability Exposure
From an administrative and risk-management standpoint, regulatory positioning is a major variable in any cost analysis. The FDA regulates the devices used to manufacture PRP through the 510(k) clearance pathway. Standard laboratory blood collection tubes (such as yellow-top ACD tubes or lavender-top EDTA tubes) are cleared for in vitro diagnostic testing—meaning blood goes into the tube to be analyzed by a machine and discarded, not to be reinjected into a human patient.
Using diagnostic tubes in an open system to prepare an injectable biologic places the burden of sterility validation and off-label device liability squarely on the physician and the practice. Closed PRP systems with specific 510(k) clearance for autologous preparation mitigate this administrative risk and simplify audits from malpractice carriers and state medical boards.
4. Ancillary Supplies and Inventory Management
Open systems require practice managers to track, order, and match expiration dates across six to eight separate SKUs per procedure (draw needles, transfer hubs, multiple tubes, vials of ACD-A, long blunt-tip needles, and multiple syringes). Closed systems consolidate these components into a single kit SKU, reducing inventory carrying costs, expiration waste, and stockout disruptions.
Direct Comparison Checklist for Practice Managers
Use this operational checklist when comparing vendor proposals for your devices and biologics suite:
- Direct Consumable Cost per Procedure: Low in open systems; moderate-to-high in closed systems.
- FDA 510(k) Clearance for Reinjection: Typically absent in open lab-tube setups; standard in dedicated closed PRP kits.
- Sterility Assurance: Compromised by ambient air exposure in open systems (unless a laminar flow hood is purchased and maintained); maintained via closed-loop ports in closed systems.
- Hands-On Staff Time: High and manual in open systems; streamlined and automated in closed systems.
- Supply Chain Complexity: Multi-SKU tracking required for open systems; single-SKU kit management for closed systems.
- Operator Dependency: High variance between technicians in open systems; standardized mechanical separation in closed systems.
Clinical Perspective: Why Physicians Care About System Selection
While practice managers focus on margin, workflow, and liability, the treating physician evaluates PRP systems through the lens of cellular yield and clinical outcomes. For clinicians across specialties like orthopedics, sports medicine, sexual wellness, and aesthetics, not all PRP is biologically equivalent.
Physicians require predictable control over three hematological variables:
- Platelet Concentration Factor: Achieving a consistent multiple over baseline whole blood levels requires precise separation mechanics. Manual pipetting in an open system frequently leaves platelets trapped in the red blood cell layer or dilutes them with too much platelet-poor plasma.
- Leukocyte Content (Leukocyte-Rich vs. Leukocyte-Poor): Certain tendon pathologies may call for leukocyte-rich PRP, while intra-articular joint injections or aesthetic applications typically favor leukocyte-poor preparations to minimize acute post-injection flare-ups. Advanced closed systems allow clinicians to dial in the buffy coat capture consistently.
- Red Blood Cell (RBC) Contamination: Red blood cells are pro-inflammatory and undesirable in most regenerative and aesthetic applications. Closed systems with calibrated physical barriers or optical sensors minimize RBC carry-over far more reliably than manual human eye estimation.
When clinical outcomes are consistent, patient satisfaction increases, driving repeat utilization and cash-pay referral volume—which ultimately offsets the higher unit cost of closed consumables.
What This Means for Your Practice
If you are auditing your current regenerative medicine margins or building a new service line from scratch, take these concrete steps to finalize your procurement strategy:
- Calculate True Cost Per Treatment: Add the hourly wage of your clinical staff (multiplied by total prep and cleanup minutes) and the cost of all ancillary draw supplies to your base tube or kit price.
- Verify Regulatory Documentation: Request the FDA 510(k) summary letters from any prospective centrifuge vendor to confirm the kits are cleared specifically for preparing autologous PRP, not just diagnostic serum separation.
- Match the Kit to Your Indications: Consult with your medical director to determine whether your practice needs single-spin aesthetic kits, high-volume orthopedic dual-spin kits, or both, so you do not overpay for capacity you do not use.
- Leverage Volume Pricing: Consolidate your biologics, centrifuge kits, and general medical supplies through a licensed distributor to negotiate tiered pricing without getting locked into punitive capital leases.
Evaluating centrifuge hardware and biologics consumables requires balancing clinical precision with practice economics. To review FDA-cleared PRP systems, compare per-kit pricing tiers, or audit your current regenerative supply chain, contact Dallas Regenerative Solutions to schedule an operational consultation with our procurement specialists.
Frequently asked questions
- Why do closed PRP systems cost more per treatment than open systems?
- Closed PRP systems bundle proprietary sterile chambers, needle-less transfer ports, and pre-measured anticoagulants into a single FDA-cleared kit. The higher unit price reflects the cost of regulatory clearance, manufacturing tolerances that guarantee sterile isolation from room air, and mechanical separation components that eliminate manual pipetting.
- Are standard laboratory blood tubes legal to use for PRP injections?
- Standard laboratory vacutainer tubes are cleared by the FDA for in vitro diagnostic testing, meaning the blood is meant to be analyzed outside the body and discarded. Using diagnostic tubes to prepare an injectable biologic is considered an off-label use that transfers sterility and device liability onto the treating practice.
- How does a closed PRP centrifuge system impact staff workflow?
- A closed system reduces the number of manual steps required to isolate the buffy coat and platelet layers. Instead of carefully pipetting plasma from open tubes, medical assistants use integrated syringes or mechanical valves to extract the PRP in a fraction of the time, allowing faster room turnover and less risk of operator error.
- Can a practice get a closed PRP centrifuge without a large upfront capital outlay?
- Yes, many distributors and manufacturers offer placement programs or volume-based agreements where the centrifuge hardware cost is reduced or waived in exchange for a consistent monthly order of disposable kits. Practice managers should evaluate total annual spend across both hardware and consumables before signing an agreement.
- Do open and closed systems produce the same platelet concentrations?
- In a controlled research lab with a highly skilled technician, an open system can achieve high platelet capture, but in a busy clinical setting it is prone to significant operator variance. Closed systems standardize the separation geometry, giving physicians consistent platelet recovery and predictable leukocyte and red blood cell profiles across every patient.
